Navigation Links
Hokanson Exhibiting at MEDICA 2008
Date:11/12/2008

DUSSELDORF, Germany, Nov. 12 /PRNewswire/ -- As the exclusive official breaking news service for North American companies participating in MEDICA 2008, November 19-22, PR Newswire is featuring profiles of the exhibiting organizations. The profile of Hokanson follows below.

Company: Hokanson

Booth Number: Hall 9 /C 02

Web URL : http://www.hokanson.cc

The Hokanson company was started in the early 1970's to provide the instruments for Dr. Eugene Strandness, innovative vascular surgeon at the University of Washington, Seattle WA USA. Hokanson manufactures, sells and supports a complete line of peripheral vascular physiological testing instruments and their accessories. From the CVS4 complete vascular system to the Portable ABI Kit, Hokanson provides the highest quality products at the most reasonable cost and the best warranty. They support various modes for testing including CW (continuous wave) bi-directional Dopplers, photo plethysmography, Pneumo plethysmography and strain gauge plethysmography. Customers have a range of instruments and systems to choose from, a simple handheld Doppler to a computerized and automated arterial inflow system, depending on their needs and price range. Hokanson cuffs are the industry standard. Hokanson is ISO 13485:2003 certified, all products carry the European CE mark and where appropriate Hokanson instruments have FDA 510(k) clearance.

MEDICA 2008 will be held November 19-22 in Dusseldorf, Germany, at the Dusseldorf Fairgrounds. For more information regarding MEDICA 2008 and a listing of all exhibitors visit the MEDICA Web site:

http://www.medica.de/cipp/md_medica/custom/pub/content,lang,2/oid,155/t icket,g_u_e_s_t

About PR Newswire

PR Newswire Association LLC ('/>"/>

SOURCE Hokanson; PR Newswire Association LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Defibtech, LLC Exhibiting at MEDICA 2008
2. Brown Medical Industries Exhibiting at MEDICA 2008
3. Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th
4. Cleveland Clinic Unveils Top 10 Medical Innovations for 2009
5. Hospitals to Lose an Average $10,000 to $20,000 per Case on Common Cardiovascular Procedures Under Medicares Value-based Purchasing Program
6. Video: CVS/pharmacy and National Council on Aging Help Seniors to Find the Right Prescription for Medicare Savings
7. CACI Awarded Three Contracts Worth $30 Million to Support Defense Medical Logistics Development
8. Amedica Receives CE Mark for the Worlds First FDA-Cleared Valeo(TM) Ceramic Spinal Implant System
9. Symmetry Medical Reports Third Quarter 2008 Financial Results
10. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
11. Leading Physicians To Host Medical Device Related Infection Prevention CME Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 1GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 2GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 3GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 4GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 5GeoVax Labs Inc Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 15013 6nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 6632 1nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 6632 2MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 1MedQuist Integrates Search Engine from Primordial with SpeechQ 28TM 29 for Radiology 6630 2